In recent years, hydrogen sulfide (H 2 S) has been reported as a gaseous modulator acting in several tissues in health and disease. In animal models of systemic inflammation, the plasma H 2 S concentration increases in response to endotoxin (bacterial lipopolysaccharide, LPS). The most striking response in the acute phase reaction of systemic inflammation is fever, but we found no reports of the peripheral action of H 2 S on this thermoregulatory response. We aimed at investigating whether endogenous systemic H 2 S modulates LPS-induced fever. A temperature datalogger capsule was inserted in the abdominal cavity of male Wistar rats (220-270 g) to record body core temperature. These animals received an I.P. injection of a systemic H 2 S inhibitor (propargylglycine; 50 or 75 mg kg −1 ), immediately followed by an I.P. injection of LPS (50 or 2500 g kg −1 ), and were exposed to different ambient temperatures (16, 22 or 27 • C). At 22 • C, but not at 27 • C, propargylglycine at 75 mg kg −1 significantly attenuated (P < 0.0001) the fever induced by LPS (50 g kg −1 ), indicating a modulatory (permissive) action of endogenous peripheral H 2 S on brown adipose tissue (BAT) thermogenesis. Evidence on the modulatory role of peripheral H 2 S in BAT thermogenesis was strengthened when we discarded (i) the possible influence of the gas on febrigenic signalling (when measuring plasma cytokines), and (ii) its interaction with the nitric oxide pathway, and mainly when (iii) we carried out physiological and pharmacological activations of BAT. Endogenous peripheral H 2 S modulates (permits) BAT activity not only in fever but also during maintenance of thermal homeostasis in cold environments.
INTRODUCTION
Gaseous molecules, such as nitric oxide (NO), carbon monoxide (CO) and, more recently, hydrogen sulfide (H 2 S), have been studied as modulators of systemic inflammation induced by endotoxin, also known as bacterial lipopolysaccharide (LPS; Branco, Soriano, & Steiner, 2014) . Studies show that H 2 S can act as a pro-or anti-inflammatory modulator (Li, Salto-Tellez, Tan, Whiteman, & Moore, 2009 ) in rats (Anuar et al., 2006) and mice (Li et al., 2005) treated with LPS.
higher in peripheral tissues (Abe & Kimura, 1996; Yang et al., 2008 ). An irreversible inhibitor of CSE, propargylglycine (PPG), has been widely used as a pharmacological tool to inhibit peripheral production of H 2 S, including use in animal models of systemic inflammation (Collin et al., 2005; Zhang, Zhi, Moore, & Bhatia, 2006) .
Evidence on the central (intracerebroventricular) role of H 2 S in the thermoregulatory response to systemic inflammation has been recently reported, particularly the central effect of H 2 S on the hypothermia of endotoxic shock (Fernández et al., 2016) . However, it is not known whether endogenous peripheral (systemic) H 2 S plays a role in thermoregulation and fever.
Fever is the most prominent and familiar acute-phase response to systemic inflammation (Blatteis, 2006; Blatteis, Sehic, & Li, 2000) and, by definition, is a regulated increase in body core temperature (T c ; Blatteis, 2006; Kluger, 1991) . A febrile response to LPS in rats and mice can be generated by the activation of one of two distinct thermoeffector mechanisms: increased brown adipose tissue (BAT) thermogenesis [when ambient temperature (T a ) is subthermoneutral] or cutaneous (tail skin) vasoconstriction (when T a is suprathermoneural or thermoneutral; Liu et al., 2012) . Thus, a determining factor for the activation of one of these two thermoeffector mechanisms is the T a to which the animal is exposed. Besides T a , it is worth mentioning that other factors, such as the LPS dose and the animal's energy reserves, also markedly influence the activation (or inhibition) of these and/or other thermoeffectors by the hypothalamus and, consequently, the thermoregulatory response, i.e. fever or hypothermia. Briefly, when the animal is exposed to an isothermal, subthermoneutral environment (22 • C, for example, i.e. below the thermoneutral temperature range), given that tail skin vasoconstriction is already activated, BAT thermogenesis has to be increased to elevate heat production so as to maintain T c (thermal homeostasis). In fever, especially when T a is subthermoneutral, it is not surprising that BAT activity has to be even more increased in order to raise T c (Cannon & Nedergaard, 2004) . Conversely, when T a is thermoneutral or suprathermoneutral (27 • C, for example), BAT thermogenesis does not need to be activated in response to LPS, but instead the tail skin vasculature can be constricted to reduce heat loss in order to mount fever (Liu et al., 2012) .
Given that (i) plasma H 2 S concentrations have been shown to be increased in response to LPS, (ii) the gas is an important modulator of LPS-induced systemic inflammation, (iii) nothing is known about its peripheral (systemic) participation in fever, and (iv) fever thermoeffector mechanisms might be different depending on the T a and dose of LPS, it seems reasonable to investigate the putative role of endogenous peripheral H 2 S in fever evoked by different LPS doses and at different ambient temperatures. To our knowledge, it is not known whether this gaseous molecule modulates heat loss (tail skin vasoconstriction; in fever and/or in cold environments) and/or is capable of regulating (again, in fever and/or in cold environments) non-shivering thermogenesis, which is known to be stimulated by sympathetically mediated 3 -adrenoceptor activation and generated by thermogenin (Ucp1) in brown adipocytes (Monda, Amaro, Sullo, & De Luca, 1995) . Thus, we hypothesized that endogenous systemic H 2 S modulates fever and can also participate in thermal homeostasis in cold environments. To test this hypothesis mechanistically, we injected
New Findings
• What is the central question of this study?
In fever, the most striking response in the acute phase reaction of systemic inflammation, plasma H 2 S concentration increases. However, the role of endogenous peripheral H 2 S in fever is unknown.
• What is the main finding and its importance?
Endogenous peripheral H 2 S is permissive for increased brown adipose tissue thermogenesis to maintain thermal homeostasis in cold environments as well as to mount fever. This finding expands the physiological role of the gaseous modulator as a key regulator of thermal control in health (thermal homeostasis) and disease (fever in systemic inflammation).
an inhibitor of peripheral H 2 S synthesis and submitted the rats to different ambient temperatures and challenges: LPS-induced systemic inflammation (endotoxaemia and endotoxic shock), cold exposure (physiological activation) and pharmacological activation of brown adipocytes.
METHODS

Ethical approval
All the procedures adopted in the present work were approved and carried out according to the guidelines laid down by the University of São Paulo Ethical Committee on the Use of Animals (CEUA; protocol no. 12.1.326.53.8). The institution operates under national guidelines (National Council of Animal Experimentation Control; CONCEA), which conform to international principles and regulations.
Origin and source of the animals
The animals were provided by the local Experimental Animal Facility (University of São Paulo, Campus of Ribeirão Preto). Male Wistar rats (220-310 g) were group housed (four animals per cage) with a lightdark cycle of 12 h-12 h and controlled temperature (25 ± 0.5 • C). Most experimental procedures were performed on groups of seven animals.
Access to food and water
Animals had free access (ad libitum) to food and water at any moment of the study (before, during and after experiments), regardless of the protocol.
Method of killing
Animals were killed by overdose of the anaesthetics ketamine (10%; Agener União, Brazil) and xylazine (200 mg; Dopaser, Hertape Calier, Brazil).
Anaesthetic protocols
Surgical procedures were performed under general anaesthesia with ketamine and xylazine (100 and 10 mg kg −1 I.P., respectively).
The animals were kept under deep general anaesthesia throughout the surgical procedures and received supplementary doses of the anaesthetics whenever necessary. Immediately after surgery, the animals were under appropriate postsurgical care. They were prophylactically treated with antibiotics [Pentabiótico veterinário pequeno porte; 160,000 U kg −1 benzylpenicillin, 33.3 mg kg −1 streptomycin and 33.3 mg kg −1 dihydrostreptomycin; 1 ml kg −1 , I.M. (2,400,000 UI, Fort Dodge Animal Health, São Paulo, Brazil)] and received analgesic medication (Banamine (flunixin meglumine), Flunexin, MSD, Brazil; 5 mg kg −1 ; 1 ml kg −1 , S.C.). We have taken all steps to minimize the animals' pain and suffering before, during and after the surgeries and during the experiments.
Surgical procedures
A median laparotomy was performed to insert a temperature datalogger capsule (SubCue, Calgary, AB, Canada) into the peritoneal cavity. The experiments were performed 7 days after this surgery.
For 3 -adrenergic agonist administration, 1 day before experimental procedure, a polyethylene catheter was inserted into the left femoral vein. The catheter was tunnelled subcutaneously and exteriorized at the nape, and surgical incision sites were sutured. The animals were maintained in individual cages during the recovery period and until the completion of the experimental protocol.
Monitoring
The depth of the general anaesthesia was frequently evaluated by noxious tail pinch, and maintained by I.P.injections of supplementary doses of the anaesthetics.
Terminal procedures
At the end of the study, the animals were killed by an overdose of the anaesthetics and properly discarded according to the local institutional guidelines.
Confirmation of compliance
We understand the ethical principles under which the journal operates.
Our work complies with the journal animal ethics checklist.
Drugs
The inhibitor of the H 2 S-synthesizing enzyme CSE (propargylglycine; PPG), the agonist of 3 -adrenergic receptors (CL 316, 243) and endotoxin (lipopolysaccharide, LPS; from E. coli, serotype 0111: B4) were obtained from Sigma (St Louis, MO, USA). The drugs were dissolved in sterile saline and stored at −20 • C; except the adrenergic agonist, which was dissolved and immediately administered. Doses of PPG were 50 and 75 mg kg −1 (PPG50 and PPG75, respectively), 5 ml kg −1 , I.P.; doses of LPS were 50 and 2500 g kg −1 (LPS50 and LPS2500, respectively), 1 ml kg −1 , I.P.; and the dose of the 3 -adrenergic agonist was 1 mg kg −1 , 1 ml kg −1 , I.V. Sterile saline was the vehicle for all drugs used in the present study, and was administered to control animals at a volume equal to that of the drug solutions, as follows: 5 ml kg −1 , I.P.
(control for PAG); 1 ml kg −1 , I.P. (control for LPS); and 1 ml kg −1 , I.V.
(control for the 3 -adrenergic agonist).
Core temperature recordings
Two days before the experimental procedure, the animals were kept in individual cages, with access to water and food ad libitum, in a small experiment room. The small experiment room also had a lightdark cycle of 12 h-12 h, and its T a was set and kept constant by a cooling/warming device. The T a of the small experiment room before the experiments was 25 ± 0.2 • C. The T a during the experiments was set to 16, 22 or 27 ± 0.2 • C, and was continuosly monitored/registered by thermometers and temperature datalogger capsules. The T c was recorded throughout the experiments by the temperature datalogger capsule surgically inserted into the peritoneal cavity. The T c was recorded at 5 min intervals, including the first 60 min before any manipulation (baseline values of T c ).
Plasma nitric oxide (nitrate, NO x ) measurements
After the I.P. treatments (see section 2.14 Experimental protocols), the animals were killed by anaesthetic overdose, decapitated and blood samples (∼5 ml) collected in heparinized tubes (0.2 ml heparin, 10 U ml −1 ) kept on ice. The samples were centrifuged (1200g, 4 • C, 20 min) to obtain plasma. Plasma was stored at −70 • C until the assay to measure a stable NO metabolite, nitrate (NOx). Fifty microlitre aliquots of plasma were deproteinized; absolute ethanol (100 l, 4 • C) was added to the samples, and they were placed at −20 • C for 30 min and subjected to centrifugation (4000 g, 25 • C, 10 min). The plasma NO x concentration was obtained by the NO/ozone chemiluminescence technique in an NO analyser (Sievers, Nitric Oxide Analyzer 280; GE Analytical Instruments, Boulder, CO, USA; Soriano, Kwiatkoski, Batalhao, Branco, & Carnio, 2012) .
Measurements of plasma levels of cytokines
Blood and plasma were collected and obtained from the same animals by the procedures described in the previous subsection (2.12). Measurements of plasma levels of tumour necrosis factor-(TNF-), interleukin-1 (IL-1 ) and interleukin-6 (IL-6) were performed by specific enzyme-linked immunosorbent assays, following the manufacturer's instructions, using DuoSet ELISA Development System (R&D Systems, Minneapolis, MN, USA). The detection limits for TNF-, IL-1 and IL-6 were 5, 5 and 21 pg ml −1 , respectively.
Experimental protocols
2.14.1 Protocol 1: effects of PPG on euthermia of rats exposed to different ambient temperatures At a T a of 22 or 27 • C, an I.P. injection of PPG (50 or 75 mg kg −1 ) immediately followed by an I.P. injection of sterile saline (vehicle of LPS, 1 ml kg −1 ) were applied to euthermic rats. The T c was continuously recorded for 60 min before any manipulation plus 8 h after injections.
Control groups received injections of sterile saline (vehicle of both PPG and LPS).
Protocol 2: effects of PPG on LPS-induced fever of rats exposed to different ambient temperatures
At 27 • C, a temperature at which fever is generated mainly through cutaneous vasoconstriction, I.P. injection of PPG (50 or 75 mg kg −1 ) was immediately followed by an I.P. injection of LPS (50 or 2500 g kg −1 ). At 22 • C, a temperature at which fever is generated through increased BAT thermogenesis, I.P. injection of PPG (50 or 75 mg kg −1 ) was immediately followed by an I.P. LPS injection (50 g kg −1 , I.P.).
The higher dose of LPS (2500 g kg −1 ) was not injected at 22 • C because it is well known that high doses of LPS administered to rats exposed to subthermoneutral environments (22 • C) evoke hypothermia. Core temperature was continuously recorded for 60 min before any manipulation plus 8 h after injections. Control groups received injections of sterile saline (vehicle of both PPG and LPS).
Protocol 3: measurements of plasma concentrations of NO (nitrate, NO x ) of euthermic and febrile rats with or without PPG treatment and exposed to different ambient temperatures
At 27 • C, groups of rats received saline or PPG at 75 mg kg −1 , immediatelly followed by an I.P. injection of LPS at 2500 g kg −1 . At 22 • C, other groups of animals received either an I.P. injection of saline or 75 mg kg −1 of PPG with or without an I.P. injection of saline or LPS at 50 g kg −1 . All animals were killed by an overdose of anaesthetics and decapitated 150 min after injections, and blood was collected in heparinized tubes and kept on ice for further processing as described in section 2.12.
2.14.4
Protocol 4: measurements of plasma concentrations of cytokines of euthermic and febrile rats with or without PPG treatment and exposed to different ambient temperatures
The blood collected for the protocol 3 (NO x measurements) was also used for the measurement of plasma cytokines. After centrifugation to obtain plasma, except for 50 l used for the NO x measurements, the plasma was used for processing specific enzyme-linked immunosorbent assays following the manufacturer's instructions.
2.14.5
Protocol 5 
Protocol 6: effect of PPG on hyperthermia induced by a 3 -adrenoceptor agonist
At 27 • C, a temperature at which BAT activity is not physiologically activated, an I.V. injection of 1 mg kg −1 of a 3 agonist was immediately followed by an I.P. injection of PPG (75 mg kg −1 ). The control group received an I.V. injection of the 3 agonist (1 mg kg −1 ) immediately followed by an I.P. injection of sterile saline (vehicle of PPG). The T c was continuously recorded for 60 min before any manipulation plus 8 h after injections.
Statistical analysis
Results are expressed as means (SD). Differences in T c between the groups for each experimental protocol were assessed by statistical analysis of the area under the curve (AUC). This statistical method of analysis of thermal fluctuations has much more biological relevance than the analyses reported in many articles worldwide that compare point-to-point changes in T c . This is because it takes into consideration that a given treatment has a statistically significant (and biological) effect on T c if, and only if, it causes a relatively longer (and not punctual) effect on it, an effect which genuinely potentiates or attenuates the parameter or its response to a given challenge 
RESULTS
Effects of PPG on euthermia at a T a of 27 • C
We evaluated whether inhibition of systemic production of H 2 S alters T c (affects T c homeostasis, euthermia) of rats exposed to 27 • C.
Injection of PPG (50 mg kg −1 , I.P.) immediately followed by an I.P. injection of sterile saline (vehicle of LPS, 1 ml kg −1 ) did not change T c (P > 0.05) when compared with control animals (data not shown).
Likewise, we observed that PPG at a higher dose (75 mg kg −1 , I.P.) did not significantly alter T c (P = 0.1922) when compared with control rats [saline + saline (n = 7), 106.1 ± 35.32 • C min versus PPG75 + saline (n = 7), 136.8 ± 22.54 • C min; 95% CI −82.03 to 20.49; Figure 1a ,b].
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Effects of PPG on fever at a T a of 27 • C
To attain the mail goal of the present work, we investigated the putative role of endogenous peripheral H 2 S in LPS-induced fever.
The febrile response to LPS can be evoked by a relatively low dose (50 g kg −1 , I.P.). This dose induces fever in animals exposed to subthermoneutral, thermoneutral or suprathermoneutral environments.
Nonetheless, the thermoeffector mechanism activated to mount fever in response to a low dose of LPS (50 g kg −1 , I.P.) might vary depending on the T a . For instance, it is well known that at a T a of 27 • C (suprathermoneutral/thermoneutral) fever is generated mainly through tail skin vasoconstriction (reduction of heat loss). Curiously, at 27 • C we observed that PPG at 50 [ Figure 1c ,e (left bars)] or at 75 mg kg −1
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Saline (5 mL kg−1, ip) + LPS (50 micrograms kg−1, 1 mL kg−1, ip) (7) PPG (50 mg kg −1, 5 mL kg−1, ip) + LPS (50 micrograms kg−1, 1 mL kg−1, ip) (7) Saline (5 mL kg−1, ip) + LPS (50 micrograms kg−1, 1 mL kg−1, ip) (7) PPG ( To study these possibilities, we first tested PPG (75 mg kg −1 ) in endotoxin-shocked rats. We evaluated whether PPG at 75 mg kg −1 would affect fever evoked by a relatively high dose of LPS. It is important to remember that LPS at high doses, such as 2500 g kg −1 (1 ml kg −1 , I.P.), may induce fever [when T a is suprathermoneutral/thermoneutral (27 • C)] or hypothermia [when T a is subthermoneutral (22 • C)]. We observed that at 27 • C PPG (75 mg kg −1 ) immediately followed by LPS injection at a high dose (2500 g kg −1 , I.P.) did not produce any significant change in fever (P > 0.05) when compared with control animals (Figure 1f ,g; P = 0.8289; 95% CI −356.1 to 428.4). This finding suggested that endogenous peripheral H 2 S, once again, does not seem to modulate tail skin vasoconstriction during fever even during severe systemic inflammation (in endotoxin-shocked rats).
Effects of PPG on euthermia at a T a of 22 • C
As PPG was not capable of altering the T c of euthermic, febrile or endotoxin-shocked rats exposed to 27 • C, our second question (mentioned in the previous subsection) had to be answered: would 
Effects of PPG on fever at a T a of 22 • C
After we had verified that PPG at 50 or 75 mg kg −1 did not alter euthermia of rats exposed to 22 • C, we then investigated the putative effect of PPG on fever generated through increased BAT thermogenesis, i.e. at a subthermoneutral T a . At 22 • C, injection of PPG at the lower dose (50 mg kg −1 , I.P.) immediately followed by an I.P. (6) (6) (7) (10) (6) (6) (6) (7) (10) (6) (6) (10) (7) (6) (6) n.d. n.d. n.d.
LPS injection at 50 g kg
(10)
(7) (10) (6) (10) (7) (6) (6) n.d. n.d. n.d. Abbreviations: n.d., not detectable; n.s., not significant, by Student's unpaired t test (two groups) or by ANOVA followed by Tukey's post hoc test (three groups) PPG (75 mg kg −1 ; which had no effect on euthermia; see Figure 2a ,b).
Interestingly, for the first time, we observed a statistically significant (P < 0.0001) effect of PPG on fever; at 22 • C, injection of PPG at 75 mg kg −1 immediately followed by an injection of LPS (50 g kg −1 , I.P.) evoked a remarkable attenuation of fever when compared with control animals [saline + LPS (n = 7), 460.2 ± 79.37 • C min versus PPG75 + LPS (n = 7), 235.0 ± 76.59 • C min; P < 0.0001; 95% CI 138.2-312.3; Figure 2d ,e (right bars)]. Our findings revealed that only at 22 • C (but not at 27 • C), inhibition of peripheral H 2 S synthesis attenuated LPS-induced fever, which led us to consider a putative modulatory (permissive) effect of the gas on BAT thermogenesis during fever.
Effects of PPG on plasma concentrations of nitric oxide (NO x )
To investigate whether reduced peripheral H 2 S bioavailability would alter peripheral NO production during euthermia or fever, we evaluated by means of this protocol whether inhibition of systemic production of H 2 S alters plasma NO x concentration in euthermic and febrile rats. The observation that PPG attenuated fever only at a subthermoneutral T a (22 • C) indicated that endogenous peripheral H 2 S seems to modulate BAT thermogenesis during fever.
However, to strengthen the consistency of this finding we had to discard other ones, mainly the possibility of NO being responsible for modulation of BAT thermogenesis. It is well known that peripheral NO modulates fever and BAT activity (Steiner, Rudaya, Ivanov, & Romanovsky, 2004) . Besides, the literature shows a possible interaction between H 2 S and the NO pathway in biological systems. Therefore, to verify the possibility of an interaction between H 2 S and NO, it was necessary to test whether PPG would affect plasma concentrations of NO (Marzinzig et al., 1997) . Figure 3a At 27 • C, saline + LPS2500 (76.99 ± 14.5 mol l −1 , n = 6) versus PPG75 + LPS2500 (74.70 ± 10.3 mol l −1 , n = 7); P = 0.90; 95% CI −36.02 to 40.59, by Student's unpaired t test (Figure 3a) .]
Effects of PPG on plasma concentrations of cytokines
Given that plasma NO concentrations were not altered by PPG at 75 mg kg −1 , the effect of this inhibitor of peripheral H 2 S synthesis may no longer be attributed to the modulation by NO of BAT thermogenesis or fever in a subthermoneutral environment (Steiner et al., 2004) . However, how about the possibility of modulation by H 2 S of the circulating levels of cytokines, thus altering the febrile signalling?
To determine whether reduced H 2 S bioavailability affects plasma concentrations of cytokines, we measured the plasma concentrations of the main cytokines involved in febrigenic signalling with or without inhibition of the systemic production of H 2 S in euthermic and febrile rats. Plasma measurements of TNF-, IL-1 and IL-6 were performed on blood (plasma) obtained from the same groups of animals used in the protocol as the NO x measurements. No statistically significant change (P > 0.05; by Student's unpaired t test) was found in plasma concentrations of cytokines between the groups studied ( Figure 3b,c,d ). [Tumour necrosis factor-concentrations at 22 • C: saline + LPS50 (81.82 ± 26.5 pg ml −1 , n = 10) versus PPG75 + LPS50 (79.95 ± 36.2 pg ml −1 , n = 10), P = 0.97; 95% CI −91.12 to 94.84, by Student's unpaired t test. Tumour necrosis factor-concentrations at 27 • C: saline + LPS2500 (119.2 ± 59.0 pg ml −1 , n = 6) versus PPG75 + LPS2500 (149.2 ± 36.9 pg ml −1 , n = 7), P = 0.67; 95% CI −187.1 to 127.2, by Student's unpaired t test. Interleukin-1 concentrations at 22 • C: saline + LPS50 (353.9 ± 74.6 pg ml −1 , n = 10) versus PPG75 + LPS50 (392.5± 81.9 pg ml −1 , n = 10), P = 0.73; 95% CI −268.3 to 191.1, by Student's unpaired t test. Interleukin-1 concentrations at 27 • C: saline + LPS2500 (1902 ± 488.3 pg ml −1 , n = 6) versus PPG75 + LPS2500 (2354 ± 224.0 pg ml −1 , n = 7), P = 0.40; 95% CI −1575 to 672.2, by Student's unpaired t test. Interleukin-6 concentrations at 22 • C: saline + LPS50 (2221 ± 564.7 pg ml −1 , n = 10) versus PPG75 + LPS50 (1947 ± 435.5 pg ml −1 , n = 10), P = 0.70; 95% CI −1205 to 1753, by Student's unpaired t test. Interluekin-6 concentrations at 27 • C: saline + LPS2500 (5010 ± 1293 pg ml −1 , n = 6) versus PPG75 + LPS2500 (4745 ± 1112 pg ml −1 , n = 7), P = 0.88; 95% CI −3464 to 3995, by Student's unpaired t test.] These findings strenghtened the observation that the effect of peripheral H 2 S on fever at 22 • C was not attributable to modulation of cytokine-mediated febrigenic signalling.
Effects of PPG on hypothermia induced by exposure to cold (16 • C)
Given that the set of findings until this point of our work suggested that the effect of PPG was on fever generated via BAT thermogenesis, we became motivated to study whether peripheral H 2 S would specifically modulate BAT activity (BAT thermogenesis). As the effect of PPG on fever was observed only at 22 • C and with no change in plasma concentrations of NO and cytokines, it seemed plausible to consider that its effect was attributable to modulation of thermogenic mechanisms in BAT. We investigated the putative effect of endogenous peripheral H 2 S on T c homeostasis during cold exposure (physiological activation of BAT). A group of animals was exposed to a T a of 16 • C, at which there is intense BAT activity in an attempt to maintain T c homeostasis, and treated with PPG at 75 mg kg −1 (Figure 4a,b) . This PPG-treated group showed a drastic, statistically significant decrease in T c when compared with the control group (P = 0.0003; 95% CI 220.6-548.9) [saline + saline, −148.0 ± 80.44 • C min (n = 7) versus saline + PPG75, −532.7 ± 182.4 • C min (n = 7); Figure 4b ].
Effects of PPG on hyperthermia induced by
-adrenergic receptor activation
To evaluate selectively whether increased BAT thermogenesis would be altered (attenuated) by the reduced H 2 S bioavailability, we performed pharmacological activation of BAT by means of an I.V.
injection of a 3 -adrenergic receptor agonist (CL 316, 243 ) and inhibited systemic production of H 2 S with PPG. Once it was verified that physiological activation of BAT thermogenesis was altered by PPG, we proceeded to evaluate whether the effect of PPG would also be observed by a selective, pharmacological activation of BAT.
To attain this goal, we injected 1 mg kg −1 (1 ml kg −1 , I.V.) of the 3 -adrenergic receptor agonist followed by an I.P. injection of PPG at 75 mg kg −1 . It is well known that 3 -adrenergic receptors are highly expressed in brown adipocytes and mediate the intracellular effects of the sympathetic activity on BAT. We observed that PPG at 75 mg kg −1 significantly attenuated (P = 0.0179; 95% CI 44.07-378.5) the agonistinduced hyperthermia when compared with the control group, which received the same agonist dose followed by an I.P. injection of saline 
DISCUSSION
The results of the present study indicate that inhibition of endogenous peripheral H 2 S synthesis with PPG at 75 mg kg −1 does not cause significant changes in T c of euthermic and febrile rats exposed to 27 • C.
In contrast, at a T a of 22 • C PPG at 75 mg kg −1 causes a significant attenuation of fever, with no effects on euthermia. As attenuation of fever occurred only at 22 • C, a propyretic action of H 2 S favouring the thermogenic activity of BAT is suggested, with a minor influence on cutaneous vasoconstriction.
The permissive role of H 2 S for BAT thermogenesis became more noticeable when we performed physiological and pharmacological activation of BAT. Physiological activation of BAT (Cannon & Nedergaard, 2004) Non-shivering thermogenesis in BAT is evident in subthermoneutral environments (22 • C, for example), when the body needs to increase heat production to maintain thermal homeostasis (Cannon & Nedergaard, 2004; Foster & Frydman, 1979) or to generate fever. An important result of the present study was that animals exposed to 22 • C and treated with PPG showed a significant attenuation of LPS-induced fever (Figure 2d ,e), with no change in euthermia (Figure 2a,b) , suggesting that the gas modulates fever.
Curiously, when we administered PPG at 50 or 75 mg kg −1 at a T a of 27 • C there were no significant changes in euthermia or fever induced by different doses of LPS (50 and 2500 g kg −1 ). Given that the main thermoeffector mechanism activated to mount fever at this T a is cutaneous vasoconstriction (Blatteis, 2006; Liu et al., 2012 ), these findings suggested that H 2 S does not seem to modulate skin vasomotor tone. It is important to remember that high doses of LPS (2500 g kg −1 , for example) evoke fever or hypothermia followed by fever, depending on the T a (Almeida, Steiner, Branco, & Romanovsky, 2006; Krall, Yao, Hass, Feleder, & Steiner, 2010; Liu et al., 2012) . In the present work, to study the putative role of H 2 S in fever generated during a severe form of systemic inflammation, we injected a high dose of LPS (2500 g kg −1 ) in animals exposed to 27 • C. Importantly, even in these endotoxin-shocked rats, H 2 S did not affect the febrile response to LPS at 27 • C (Figure 1f,g ).
Given that fever was attenuated by PPG only at 22 • C, to explore other possible mechanisms by which H 2 S alters the febrile response to LPS at 22 • C, one possibility had to be considered and investigated:
would the H 2 S modulation of fever be indirectly mediated by NO? The literature states that, like H 2 S, NO is a gaseous modulator of systemic inflammation (Li et al., 2005; Zhu, Liu, Liu, Wang, & Ni, 2010) and fever (Steiner et al., 2004) , and that a systemic interaction may occur between the H 2 S and NO pathways (Branco et al., 2014) . When nitrate (NO x ; a stable metabolite of NO) was measured, we observed that there was no significant difference between the groups (Figure 3a) , which ruled out the possibility of interaction between the pathways of H 2 S and NO. It was important to verify this possibility because it is known that NO modulates fever generated through increased thermogenesis in BAT (Steiner et al., 2004 (Cannon & Nedergaard, 2004; Nisoli, Tonello, Briscini, & Carruba, 1997; Oelkrug et al., 2015) . However, there are no studies, to date, showing the influence of H 2 S on thermogenesis produced by brown adipocytes. It remains to be determined whether H 2 S modulates noradrenaline release from sympathetic terminals innervating BAT and/or alters intracellular events in brown adipocytes involved in heat production.
It is well known that cytokines are particularly involved in the LPSinduced febrigenic signalling to the brain. Our results showed that H 2 S did not alter plasma cytokine (TNF-, IL-1 and IL-6) concentrations of any group studied (Figure 3b,c,d ). These findings, together with the observation that peripheral H 2 S modulates fever at 22 but not at 27 • C (which is per se an even more conclusive result), ruled out the possibility of the modulation of febrigenic signalling by H 2 S. Therefore, the modulatory role of the gas in BAT thermogenesis during fever at 22 • C (subthermoneutral environments) became even stronger after the demonstration that the gas does not alter either plasma NO concentrations or cytokine-mediated febrigenic signalling.
Nonetheless, one may argue that the plasma concentration of another fever mediator (or mediators) might be altered by peripheral H 2 S, thus accounting for the modulatory effect of the gas on fever. Even though we do not completely discard this possibility, it is very important (crucial) to remember that if peripheral H 2 S (its reduced bioavailability) had modulated the plasma concentration of another relevant fever mediator or mediators (for example, prostaglandin E 2 ; Kwiatkoski et al., 2013) , fever would be attenuated at any T a , i.e. at 22 and at 27 • C. In other words, given that H 2 S attenuated fever only at 22 • C, we conclude that febrigenic signalling is not influenced by the gas.
Taken together, the findings of the present study suggest that endogenous peripheral H 2 S does not modulate either febrigenic signalling or plasma concentrations of NO during fever, but instead is permissive for increased BAT activity, thereby favouring (i) the febrile response to LPS (propyretic role) and (ii) T c homeostasis in cold environments (thermal homeostatic role). Studies on the intracellular (molecules involved in thermogenesis in brown adipocytes) and/or physiological and electrophysiological effects of the gas (on sympathetic terminals innervating BAT) have to be performed, because there is a need to expand knowledge of the actions of endogenous H 2 S as a modulator of BAT thermogenesis-dependent T c homeostasis and fever.
